Presentation Information
[3P-315]Engineering of Cross-Reactive Single-Domain Antibodies Targeting SARS-CoV2 Variants
○Hidekazu Masaki1,2, Ryo Yonehara1, Kanako Nakao1, Naoto Nemoto1,2 (1. Epsilon Molecular Engineering, 2. Saitama Univ.)
Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in